Pro Share Advisors LLC Bridge Bio Pharma, Inc. Transaction History
Pro Share Advisors LLC
- $42.9 Billion
- Q1 2025
A detailed history of Pro Share Advisors LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 39,020 shares of BBIO stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,020
Previous 48,539
19.61%
Holding current value
$1.79 Million
Previous $1.33 Million
1.28%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BBIO
# of Institutions
370Shares Held
184MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$1.01 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$882 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$682 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$570 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$328 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.79B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...